Iazsmin Ventura to Receptors, Interleukin-6
This is a "connection" page, showing publications Iazsmin Ventura has written about Receptors, Interleukin-6.
Connection Strength
0.094
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
Score: 0.094